25/08/2026
Long sleeves in a Nairobi heat wave. Scarves in July. The careful angle of a handshake, wrist turned inward.
She'd had psoriasis since she was nineteen. Raised, silvery patches on her elbows, then her knees, her scalp. Doctors called it a chronic autoimmune condition. Strangers on the matatu called it, without words, with a stare that lasted half a second too long.
Here's what most people do not know: psoriasis is not contagious. It is not poor hygiene, or an allergy, or anything Njeri did wrong. It is her immune system misfiring, telling her skin cells to grow ten times faster than they should.
About 2 to 3% of people worldwide live with it. In Kenya, that number is likely undercounted, not because the condition is rare, but because the data is. Cases go undiagnosed, misdiagnosed, or simply endured in silence.
That's the real tragedy. Not the disease itself, but its invisibility.
is a long game. It flares, fades, flares again, shaped by stress, weather, infections, even a change in medication. Managing it well means tracking it well, across the dermatology clinic, the pharmacy, and the insurer. Too often, those three do not talk to each other, and patients like Njeri fall through the gap.
This is where Afyanalytics comes in. We do not treat patients. We build the systems that help the people who do. We integrate health data across hospitals, laboratories, pharmacies and insurers, so a patient's journey is not lost between disconnected systems. And we deliver real time insights that help providers spot patterns before they become a crisis, a flare season, a treatment that is not working, a patient who's gone quiet.
Njeri's psoriasis has not disappeared. But she stopped counting sleeves the day her care stopped feeling like a guessing game, when her dermatologist, pharmacist and insurer were finally looking at the same picture of her.
Awareness starts with a story. Change starts with the data behind it.